Skip to main content

CLOUGH CAPITAL PARTNERS L P

Position in CRSP — CRISPR Therapeutics AG

CIK 1276144 Boston, MA

Position in CRSP

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,363,299
+$4,189,034 QoQ
Shares Held
98,337
+298.4% QoQ
Ownership
0.102%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#70
of 519 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRSP Over Time

Shares Held

Position Value (USD)

Derivatives in CRSP

reported options exposure · as of Dec 31, 2021
CallValue
$6,123,024
CallShares
80,800
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CLOUGH CAPITAL PARTNERS L P holds $12,298,984 across 3 Biotechnology names. CRSP ranks #1 (43.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CRSP
CRISPR Therapeutics AG
This page
98,337 $5,363,299

All Filings in CRSP

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,363,299 98,337
2026-03-31 $1,174,265 24,685
2025-12-31 $1,206,120 23,000
2025-09-30 $1,490,630 23,000
2024-12-31 $2,251,392 57,200
2024-06-30 $1,130,915 20,939
2023-12-31 $327,147 5,226
2023-06-30 $3,198,239 56,969
2023-03-31 $5,522,583 122,100
2022-12-31 $10,638,105 261,700
2022-09-30 $27,105,023 414,767
2022-06-30 $19,280,315 317,267
2022-03-31 $12,937,336 206,107
2021-12-31 $6,123,024 80,800
2021-12-31 $8,033,210 106,007
2021-09-30 $15,816,492 141,307
2021-06-30 $28,034,005 173,167
2021-06-30 $39,258,325 242,500
2021-03-31 $22,783,147 186,977
2021-03-31 $13,281,650 109,000
2020-12-31 $22,202,021 145,007
2020-09-30 $22,317,410 266,827
2020-06-30 $21,828,514 297,027
2020-06-30 $7,150,577 97,300
2020-03-31 $12,596,915 297,027
2020-03-31 $8,753,424 206,400